Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from NATCO Pharma Limited ( (IN:NATCOPHARM) ).
Natco Pharma Limited’s Board of Directors has declared an interim dividend of Rs. 2 per equity share for the financial year 2025-26, with the record date set for August 19, 2025, and payment commencing on August 26, 2025. Additionally, the Board approved an increase in the company’s authorized capital to Rs. 45 crore, subject to shareholder approval, and announced plans for the 42nd Annual General Meeting to be held via video conference.
More about NATCO Pharma Limited
Natco Pharma Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic pharmaceuticals. The company is known for its strong presence in the oncology and specialty pharmaceuticals market.
Average Trading Volume: 76,762
Technical Sentiment Signal: Sell
Current Market Cap: 161.2B INR
For a thorough assessment of NATCOPHARM stock, go to TipRanks’ Stock Analysis page.